CUFinder

Shaomeng Wang

Shaomeng Wang

University of Michigan

H-index: 105

North America-United States

Contact Shaomeng Wang

About Shaomeng Wang

Shaomeng Wang, With an exceptional h-index of 105 and a recent h-index of 57 (since 2020), a distinguished researcher at University of Michigan, specializes in the field of drug discovery and medicinal chemistry.

His recent articles reflect a diverse array of research interests and contributions to the field:

Chroman derivatives as estrogen receptor degraders and their preparation

Indazole derivatives as estrogen receptor degraders

Transient BRD4 degradation improves cardiac reprogramming by inhibiting macrophage/Oncostatin M induced JAK/STAT pathway

Corrigendum to “Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment”[Neoplasia, Volume 22, Issue 2 (2020) 111–119]

Imidazo [4, 5-c] pyridine compounds as LSD-1 inhibitors

Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer

Discovery of oral SMARCA2 degraders for the treatment of SMARCA4 mutant tumors

The selective IKZF2 molecular glue degrader, PVTX-405, counters Treg immune suppression, shows significant tumor growth delay as single agent and synergistic response with …

Shaomeng Wang Information

University

Position

___

Citations(all)

39741

Citations(since 2020)

13721

Cited By

31467

hIndex(all)

105

hIndex(since 2020)

57

i10Index(all)

361

i10Index(since 2020)

243

Email

University Profile Page

Google Scholar

Shaomeng Wang Skills & Research Interests

drug discovery and medicinal chemistry

Top articles of Shaomeng Wang

Chroman derivatives as estrogen receptor degraders and their preparation

2024/2/1

Indazole derivatives as estrogen receptor degraders

2024/2/1

Transient BRD4 degradation improves cardiac reprogramming by inhibiting macrophage/Oncostatin M induced JAK/STAT pathway

bioRxiv

2024

Liu Liu
Liu Liu

H-Index: 11

Shuo Tian
Shuo Tian

H-Index: 12

Zhaokai Li
Zhaokai Li

H-Index: 4

Shaomeng Wang
Shaomeng Wang

H-Index: 52

Zhong Wang
Zhong Wang

H-Index: 1

Corrigendum to “Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment”[Neoplasia, Volume 22, Issue 2 (2020) 111–119]

Neoplasia (New York, NY)

2024/5

Steven Kregel
Steven Kregel

H-Index: 13

Chao Wang
Chao Wang

H-Index: 6

Xin Han
Xin Han

H-Index: 13

Lanbo Xiao
Lanbo Xiao

H-Index: 22

Pushpinder Bawa
Pushpinder Bawa

H-Index: 6

Shaomeng Wang
Shaomeng Wang

H-Index: 52

Imidazo [4, 5-c] pyridine compounds as LSD-1 inhibitors

2024/4/2

Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer

Journal of Medicinal Chemistry

2024/3/26

Zhixiang Chen
Zhixiang Chen

H-Index: 8

Mi Wang
Mi Wang

H-Index: 11

Wei Jiang
Wei Jiang

H-Index: 4

Yu Wang
Yu Wang

H-Index: 14

Jie Luo
Jie Luo

H-Index: 9

Meilin Wang
Meilin Wang

H-Index: 36

Bo Wen
Bo Wen

H-Index: 16

Shaomeng Wang
Shaomeng Wang

H-Index: 52

Discovery of oral SMARCA2 degraders for the treatment of SMARCA4 mutant tumors

Cancer Research

2024/3/22

Zhenwu Li
Zhenwu Li

H-Index: 14

Wei Jiang
Wei Jiang

H-Index: 4

Shreyas Joshi
Shreyas Joshi

H-Index: 5

Qiaolin Deng
Qiaolin Deng

H-Index: 21

Shaomeng Wang
Shaomeng Wang

H-Index: 52

The selective IKZF2 molecular glue degrader, PVTX-405, counters Treg immune suppression, shows significant tumor growth delay as single agent and synergistic response with …

Cancer Research

2024/3/22

Zhixiang Chen
Zhixiang Chen

H-Index: 8

Shaomeng Wang
Shaomeng Wang

H-Index: 52

Discovery of highly potent, selective and efficacious STAT3 PROTAC degraders capable of achieving complete tumor regression

Cancer Research

2024/3/22

Haibin Zhou
Haibin Zhou

H-Index: 16

Bo Wen
Bo Wen

H-Index: 16

Shaomeng Wang
Shaomeng Wang

H-Index: 52

Potent and orally efficacious PROTAC degraders of estrogen receptor α (ERα)

Cancer Research

2024/3/22

Zhixiang Chen
Zhixiang Chen

H-Index: 8

Biao Hu
Biao Hu

H-Index: 2

Yu Wang
Yu Wang

H-Index: 14

Bo Wen
Bo Wen

H-Index: 16

Shaomeng Wang
Shaomeng Wang

H-Index: 52

Evaluation of a highly potent and selective STAT3 degrader as a new class of immunotherapy

Cancer Research

2024/3/22

Haibin Zhou
Haibin Zhou

H-Index: 16

Jiajia Zhou
Jiajia Zhou

H-Index: 16

Ranjan Kumar Acharyya
Ranjan Kumar Acharyya

H-Index: 3

Bo Wen
Bo Wen

H-Index: 16

Shaomeng Wang
Shaomeng Wang

H-Index: 52

Discovery of potent and highly efficacious STAT3 PROTAC degraders capable of achieving long-lasting tumor regression

Cancer Research

2024/3/22

Shaomeng Wang
Shaomeng Wang

H-Index: 52

Discovery of potent, highly selective and orally efficacious SMARCA2 degraders

Cancer Research

2024/3/22

Lin Yang
Lin Yang

H-Index: 51

Wei Jiang
Wei Jiang

H-Index: 4

Yu Wang
Yu Wang

H-Index: 14

Meilin Wang
Meilin Wang

H-Index: 36

Lu Wang
Lu Wang

H-Index: 6

Bo Wen
Bo Wen

H-Index: 16

Shaomeng Wang
Shaomeng Wang

H-Index: 52

Orally bioavailable PROTAC based MDM2 degrader

Cancer Research

2024/3/22

Shaomeng Wang
Shaomeng Wang

H-Index: 52

Discovery of CBPD-268 as an exceptionally potent and orally efficacious CBP/p300 PROTAC degrader capable of achieving tumor regression

Journal of Medicinal Chemistry

2024/3/13

Zhixiang Chen
Zhixiang Chen

H-Index: 8

Mi Wang
Mi Wang

H-Index: 11

Tianfeng Xu
Tianfeng Xu

H-Index: 10

Yu Wang
Yu Wang

H-Index: 14

Ruiting Li
Ruiting Li

H-Index: 6

Meilin Wang
Meilin Wang

H-Index: 36

Lu Wang
Lu Wang

H-Index: 6

Bo Wen
Bo Wen

H-Index: 16

Shaomeng Wang
Shaomeng Wang

H-Index: 52

Cereblon Ligands and Uses Thereof

2024/2/22

Indole derivatives as estrogen receptor degraders and their preparation

2024/2/1

Androgen receptor protein degraders with a tricyclic cereblon ligand

2023/11/9

Small Molecule Degraders of SHP2 Protein

2023/7/13

Spiro compounds as IKZF2 degraders and their preparation, pharmaceutical compositions and use in the treatment of cancer

2023/10/27

See List of Professors in Shaomeng Wang University(University of Michigan)